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 EPI Update for Friday, May 23, 2008  
Center for Acute Disease Epidemiology (CADE)  
Iowa Department of Public Health (IDPH)  
  
Items for this week’s EPI Update include:  
? Prevention of pertussis, tetanus, and diphtheria among pregnant and 
postpartum women and their infants  
? CDC recommends shingles vaccine  
? May is National Hepatitis Awareness month  
? WHO reports noncommunicable diseases now biggest killers  
? Meeting announcements and training opportunities  
  
Prevention of pertussis, tetanus, and diphtheria among pregnant and 
postpartum women and their 
infants                                                                          In 2005, two tetanus toxoid 
reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccines (ADACEL®  
 and BOOSTRIX®) were licensed and recommended for use in adults and 
adolescents in the United States. Both Tdap vaccines are licensed for single-
dose use to add protection against pertussis, and to replace the next dose of 
tetanus and diphtheria toxoids vaccine (Td)  
Available evidence does not address the safety of Tdap for pregnant women, 
their fetuses, or pregnancy outcomes sufficiently. Available data also do not 
indicate whether Tdap-induced transplacental maternal antibodies provide early 
protection against pertussis to infants or interfere with an infant's immune 
responses to routinely administered pediatric vaccines.  
Until additional information is available, CDC's Advisory Committee on 
Immunization Practices recommends that pregnant women who were not 
vaccinated previously with Tdap:  
•        Receive Tdap in the immediate postpartum period before discharge 
from hospital or birthing center. 
•        May receive Tdap at an interval as short as 2 years since the most 
recent Td vaccine. 
•        Receive Td during pregnancy for tetanus and diphtheria protection 
when indicated.  
•        Defer the Td vaccine indicated during pregnancy to substitute Tdap 
vaccine in the immediate postpartum period if the woman is likely to 
have sufficient protection against tetanus and diphtheria. 
 Although pregnancy is not a contraindication for receiving Tdap vaccine, health 
care providers should weigh the theoretical risks and benefits before choosing to 
administer Tdap vaccine to a pregnant woman. 
 For more information visit 
:www.cdc.gov/mmwr/preview/mmwrhtml/rr57e0514a1.htm?s_cid=rr57e0514a1_e  
CDC recommends shingles vaccine  
CDC’s Advisory Committee on Immunization Practices recommends a single 
dose of the zoster vaccine, Zostavax, for adults 60 years of age and older even if 
they have had a prior episode of shingles.   
Zoster vaccination is not indicated for:  
• Treatment of acute zoster, or ongoing post herpetic neuralgia (PHN).  
• Preventing case patients with acute zoster from developing post herpetic 
neuralgia (PHN).  
  
Before routine administration of zoster vaccine, it is not necessary to ask patients 
about their history of varicella (chickenpox) or to conduct serologic testing for 
varicella immunity.   
For more information visit: 
www.cdc.gov/mmwr/preview/mmwrhtml/rr57e0515a1.htm?s_cid=rr57e0515_e
  
May is National Hepatitis Awareness month 
May is National Hepatitis Awareness month.  In light of that, we’d like to give you 
some facts about hepatitis:   
• There are five distinct types of hepatitis: A, B, C, D, and E. All cause 
inflammation of the liver.  
• The hepatitis B virus is 100 times more infectious than HIV.  
• It is estimated that there are 1.4 million Americans with chronic hepatitis B.  
• Hepatitis B and C can lead to liver cancer.  
• There are vaccines for hepatitis A and B. There is no vaccine for hepatitis 
C.  
• Hepatitis C is the most common blood-borne infection in the United 
States.  
• Almost 4 million Americans, or 1.8 percent of the U.S. population, are or 
have been infected with hepatitis C.  
• Approximately 3.2 million Americans are chronically infected with hepatitis 
C.  
• Hepatitis C is now the leading indication for adult liver transplantation in 
the U.S.  
• There are an estimated 53,000 Iowans infected with hepatitis C.  
  
What hepatitis resources are available for Iowans? 
1. Hepatitis C testing services:  
Free hepatitis C testing is offered to at-risk clients at thirteen health 
agencies across the state. High-risk populations include: people who have 
ever injected drugs, injecting drug users who share needles or other 
equipment, persons who received blood, blood products, or organ 
transplants prior to 1992, or persons ever on long-term Hemodialysis.   
For more information about Hepatitis C testing sites visit: 
www.idph.state.ia.us/adper/common/pdf/hepatitis/hep_c_testing_sites.pdf  
  
      2. Hepatitis A and B vaccination services:  
Free hepatitis A and B vaccinations are offered to at-risk clients at thirteen 
health agencies across the state. High-risk populations include people who 
were diagnosed with a sexually transmitted disease in the past 90 days, 
men who have sex with men, injection and non-injection drug users, HIV- 
and/or hepatitis C-infected persons, and sexual partners of persons 
infected with HIV, hepatitis A (HAV), and/or hepatitis B (HBV).  
For more information regarding Hepatitis A and B visit:     
www.idph.state.ia.us/adper/common/pdf/hepatitis/hep_a_hep_b_vaccine_s
ites.pdf  
  
3. Viral Hepatitis Physician Treatment Directory 
The Iowa Department of Public Health has updated the Viral Hepatitis 
     Physician Treatment Directory. This directory provides a list of 
physicians who see patients for medical evaluation and treatment of viral 
hepatitis. 
For more information visit:
www.idph.state.ia.us/adper/common/pdf/hepatitis/directory_physicians_tre
ating.pdf  
  
4. Hepatitis educational materials 
Need hepatitis educational materials? Visit the HIV/AIDS/Hepatitis 
Program clearinghouse form. Obtain free brochures, pamphlets, posters, 
and DVDs to help educate patients and community members.  
For more information, visit: 
www.idph.state.ia.us/adper/common/pdf/hepatitis/hiv-
hep_clearinghouse_order_form.pdf  
  
WHO reports noncommunicable diseases now biggest killers 
The global burden of disease is shifting from infectious diseases to 
noncommunicable diseases (those that do not pass from person to person), with 
chronic conditions such as heart disease and stroke now being the chief causes 
of death globally, according to a new World Health Organization (WHO) report. 
The shifting health trends indicate that leading infectious diseases – diarrhea, 
HIV, tuberculosis, neonatal infections and malaria – will become less important 
causes of death globally over the next 20 years. 
For more information visit: 
www.who.int/mediacentre/news/releases/2008/pr14/en/index.html
  
Meeting announcements and training opportunities 
None 
  
Have a healthy and happy week!  
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